Akershus University Hospital

Research at Akershus University Hospital in Cardiovascular Diseases focuses on major heart and circulation conditions, especially acute myocardial infarction, atrial fibrillation, and stroke-related prevention. The trials are designed to improve emergency care, reduce the risk of recurrent events, and test whether new treatment approaches can better protect high-risk patients.

• Evaluating a self-administered treatment approach for people with symptoms suggesting acute myocardial infarction
• Studying stroke prevention in patients with atrial fibrillation and advanced chronic kidney disease
• Assessing whether a treatment can improve outcomes after serious brain bleeding and related vascular emergencies

This area brings together urgent cardiovascular care and prevention research, with a strong emphasis on improving survival and reducing repeat events.

The Nervous System Diseases portfolio includes studies on chronic migraine and stroke-related conditions, reflecting a focus on both symptom control and better acute care. At this site, the research aims to confirm whether existing therapies can offer more reliable benefit in everyday practice and to support faster, more effective treatment decisions.

• Testing whether atorvastatin can help prevent attacks in people with chronic migraine
• Exploring treatment strategies for patients affected by stroke and other neurologic emergencies
• Improving clinical outcomes through better understanding of treatment response in neurological disease

The work combines prevention research with efforts to strengthen real-world care for common and serious neurological disorders.

In Neoplasms, the hospital is involved in research on advanced breast cancer in older and frailer patients. These studies aim to make cancer treatment more practical and tolerable for people who may need gentler, personalized therapy while still maintaining effectiveness.

• Comparing treatment approaches for older breast cancer patients to find a better balance between benefit and side effects
• Supporting more individualized cancer care for vulnerable patients with advanced breast cancer
• Evaluating whether modified treatment strategies can improve continuation of therapy in routine oncology practice

This research reflects a patient-centered approach to oncology, with attention to treatment effectiveness, safety, and quality of life.

Work in Digestive System Diseases centers on primary sclerosing cholangitis, a chronic liver and bile duct disease with limited treatment options. The trials are focused on testing whether a potential therapy can improve disease markers and offer a better way to manage this challenging condition.

• Studying a treatment for primary sclerosing cholangitis to see whether it can lower signs of inflammation and cholestasis
• Assessing whether therapy can improve liver-related outcomes in patients with chronic biliary disease
• Exploring options that may provide more effective symptom and disease control

The focus is on finding practical improvements for a rare but serious digestive and liver disorder.

The Virus Diseases research includes monkeypox virus disease, with studies examining how patients respond to antiviral treatment and routine care. The goal is to better understand clinical outcomes and support more informed decisions about managing emerging infectious diseases.

• Observing outcomes in patients with mpox who receive antiviral treatment and those who do not
• Improving knowledge of how to manage monkeypox virus disease in real-world clinical settings
• Supporting evidence-based care for infectious disease outbreaks

This area adds an important infectious disease dimension to the site’s broader clinical research profile.